CAS NO:1138245-13-2 Mirogabalin
CAS NO:1138245-13-2 NAME:Mirogabalin MF:C12H19NO2 MW:209.28 Purity:98% Appearance:white powder COA:Provide Sample:Negotiable
Categories:
Life Science Chemicals
Pharmaceutical Intermediates
Email:sale06@alfachem.cn
Product introduction
| PRODUCT NAME | Mirogabalin |
| CAS NO | 1138245-13-2 |
| Other name | 2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid |
| BP | 357.5±15.0 °C(Predicted) |
| DENSITY | 1.104±0.06 g/cm3(Predicted) |
| STORAGE | 2-8°C |
| DELIVERY | 2-3DAYS |
| PACKAGE | According client's request |
Description of CAS NO:1138245-13-2 Mirogabalin
Mirogabalin, also known as DS-5565 CAS NO:1138245-13-2 , is a gabapentinoid medication developed by Daiichi Sankyo . It is a member of the gabapentinoid class, which also includes gabapentin and pregabalin . As a gabapentinoid, mirogabalin binds to the α2δ subunit of voltage-gated calcium channels (1 and 2), but with significantly higher potency than pregabalin . It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain .

Applications of CAS NO:1138245-13-2 Mirogabalin
1.Analgesic Effects in Fibromyalgia Models
2.Approval for Peripheral Neuropathic Pain
3.Treatment of Diabetic Neuropathy and Postherpetic Neuropathy : Mirogabalin is effective and safe in treating neuropathic pain in diabetic neuropathy and postherpetic neuropathy, with potential applications in other neuropathic pain etiologies
4.Use in Renal Impairment and Pain Associated with DPNP or PHN : Mirogabalin was well tolerated and significantly reduced pain levels in Japanese patients with renal impairment suffering from diabetic peripheral neuropathic pain or post-herpetic neuralgia
Key words:
Related Products
Related Products
Inquiry